A citation-based method for searching scientific literature

Laurent Castéra, Valentin Harter, Etienne Muller, Sophie Krieger, Nicolas Goardon, Agathe Ricou, Antoine Rousselin, Germain Paimparay, Angelina Legros, Olivia Bruet, Céline Quesnelle, Florian Domin, Chankannira San, Baptiste Brault, Robin Fouillet, Caroline Abadie, Odile Béra, Pascaline Berthet, Thierry Frébourg, Dominique Vaur. Genet Med 2018
Times Cited: 33



Hermela Shimelis, Holly LaDuca, Chunling Hu, Steven N Hart, Jie Na, Abigail Thomas, Margaret Akinhanmi, Raymond M Moore, Hiltrud Brauch, Angela Cox, Diana M Eccles, Amanda Ewart-Toland, Peter A Fasching, Florentia Fostira, Judy Garber, Andrew K Godwin, Irene Konstantopoulou, Heli Nevanlinna, Priyanka Sharma, Drakoulis Yannoukakos, Song Yao, Bing-Jian Feng, Brigette Tippin Davis, Jenna Lilyquist, Tina Pesaran, David E Goldgar, Eric C Polley, Jill S Dolinsky, Fergus J Couch. J Natl Cancer Inst 2018
Times Cited: 110




List of shared articles



Times cited


PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk.
Andromachi Vagena, Myrto Papamentzelopoulou, Despoina Kalfakakou, Panagoula Kollia, Christos Papadimitriou, Amanda Psyrri, Paraskevi Apostolou, George Fountzilas, Irene Konstantopoulou, Drakoulis Yannoukakos,[...]. J Hum Genet 2019
4

Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management.
Shijie Wu, Jiaojiao Zhou, Kun Zhang, Huihui Chen, Meng Luo, Yuexin Lu, Yuting Sun, Yiding Chen. Front Oncol 2020
10

Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers.
Wejdan M Alenezi, Caitlin T Fierheller, Neil Recio, Patricia N Tonin. Genes (Basel) 2020
5

Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome.
Tomoko Kaneyasu, Seiichi Mori, Hideko Yamauchi, Shozo Ohsumi, Shinji Ohno, Daisuke Aoki, Shinichi Baba, Junko Kawano, Yoshio Miki, Naomichi Matsumoto,[...]. NPJ Breast Cancer 2020
1

Update on Genetic Testing in Gynecologic Cancer.
Susan M Domchek, Mark E Robson. J Clin Oncol 2019
7

Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome.
Tomoko Kaneyasu, Seiichi Mori, Hideko Yamauchi, Shozo Ohsumi, Shinji Ohno, Daisuke Aoki, Shinichi Baba, Junko Kawano, Yoshio Miki, Naomichi Matsumoto,[...]. NPJ Breast Cancer 2020
5

Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study.
Na Li, Belle W X Lim, Ella R Thompson, Simone McInerny, Magnus Zethoven, Dane Cheasley, Simone M Rowley, Michelle W Wong-Brown, Lisa Devereux, Kylie L Gorringe,[...]. NPJ Breast Cancer 2021
1

BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation.
Malwina Suszynska, Wojciech Kluzniak, Dominika Wokolorczyk, Anna Jakubowska, Tomasz Huzarski, Jacek Gronwald, Tadeusz Debniak, Marek Szwiec, Magdalena Ratajska, Katarzyna Klonowska,[...]. Cancers (Basel) 2019
14

BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort.
Paula Rofes, Jesús Del Valle, Sara Torres-Esquius, Lídia Feliubadaló, Agostina Stradella, José Marcos Moreno-Cabrera, Adriana López-Doriga, Elisabet Munté, Rafael De Cid, Olga Campos,[...]. Genes (Basel) 2021
0